Recruiting
Obstructive sleep apnoea syndrome
RecruitingA Phase 3 Randomized, Double-blind,Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Maridebart Cafraglutide in Adult Participants with Obstructive Sleep Apnea not on Positive Airway Pressure Therapy and Living with Overweight or Obesity (MARITIME-OSA-2)
InvestigationalNo placebo
A Phase 3 Randomized, Double-blind,Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Maridebart Cafraglutide in Adult Participants with Obstructive Sleep Apnea not on Positive Airway Pressure Therapy and Living with Overweight or Obesity (MARITIME-OSA-2)
InvestigationalNo placebo
- Disease:Obstructive sleep apnoea syndrome
- Substances:Maridebart Cafraglutide
Countries:
Hungary
Hungary- Participants:18–64 years · 65+ years
- Substances:Maridebart Cafraglutide
- Sponsor:Amgen Inc.
